Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven research firms that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The […]
More Stories
StockNews.com Downgrades WPP (NYSE:WPP) to Hold
WPP (NYSE:WPP – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold”...
Canterra Minerals (CVE:CTM) Trading 5% Higher – Should You Buy?
Canterra Minerals Co. (CVE:CTM – Get Free Report)’s share price traded up 5% during trading on Monday . The company...
Johnson Controls International plc (NYSE:JCI) Short Interest Down 13.0% in October
Johnson Controls International plc (NYSE:JCI – Get Free Report) saw a large decrease in short interest in the month of...
Short Interest in Grindr Inc. (NYSE:GRND) Expands By 12.3%
Grindr Inc. (NYSE:GRND – Get Free Report) saw a large increase in short interest during the month of October. As...
Short Interest in Hims & Hers Health, Inc. (NYSE:HIMS) Rises By 6.2%
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) saw a large increase in short interest in the month...
Abitibi Royalties (CVE:RZZ) Shares Down 0.6% – Here’s What Happened
Abitibi Royalties Inc. (CVE:RZZ – Get Free Report) shares fell 0.6% on Monday . The company traded as low as...